Life Science Partners
Life Sciences Partners et al. in €32m round for Oxthera
Round also saw participation from Ysios Capital, Sunstone Capital and Flerie Invest
Life Sciences Partners in €17.5m Immunic series-A
Other participating investors included Bayern Kapital and High-Tech Gründerfonds
LSP leads €16.2m series-C for Vivasure Medical
Backers include Evonik Venture Capital, Panakés Partners and Fountain Healthcare Partners
LSP closes $280m life sciences venture fund
Vehicle closes more than one year after holding its first close on €80m
Gimv et al. lead €36m series-A for G-Therapeutics
Listed buyout house Gimv invested €6m in the funding round led by LSP and Inkef
LifeCare-backed Kuros raises CHF 5m extension
Company has been developing biomaterials since 2000
Atlas Genetics raises $20m
Company will launch first testing product later this year
Benelux activity strengthens despite controversies
From LuxLeaks to a $250m funding round – Benelux experienced a varied year
LSP-HEF co-leads Curetis’s series-B extension
Molecular diagnostics company has raised €63.5m since inception
Gimv et al. exit listed Prosensa
Sale resulted in 4.6x return on historial investment cost for Gimv
Capricorn et al. raise €15m in Nexstim float
Company has received €25.1m in capital since 2007
Probiodrug raises €22.5m in Euronext IPO
Fresh capital to be used for advancing development of Alzheimer's drug
LSP raises €80m for LSP 5 fund
Fund received commitment from large pharma company
VC-backed Probiodrug to list on Euronext
Consortium-backed biopharmaceutical company seeks funds for drug development
VC-backed Affimed raises $56m in IPO
Backers include Aeris, BioMedInvest and Life Sciences Partners
VC-backed arGEN-X raises €40m in IPO
Company will list on Euronext Brussels on 10 July
Seventure and LSP invest €4.4m in Mint
Funding round saw participation from existing backers
VC-backed Affimed to float
Plans to raise up to $75m in IPO, according to SEC filing
Life Sciences Partners leads Sequana Medical series-C
Existing investors also contribute to CHF 23m round
VC firms exit Activaero in trade sale
€130m proceeds to be split between cash and shares
LSP closes Health Economics Fund on €112m
Vehicle began investing in September 2012
Sector focus: An outbreak of biotech IPOs
Biotech IPOs
Benelux exit market lifts
Benelux
Inkef invests €7.5m in Sapiens
Inkef Capital has invested €7.5m in Dutch medical technology company Sapiens Steering Brain Stimulation (Sapiens), extending the company's series-A funding.